fda d.i.s.c.o. burst edition: fda approval of adstiladrin (nadofaragene firadenovec-vncg) for pat...
Published 5 months ago • 68 plays • Length 3:31Download video MP4
Download video MP3
Similar videos
-
3:31
fda d.i.s.c.o. burst edition: fda approval of keytruda (pembrolizumab) for the adjuvant treatment...
-
8:01
fda d.i.s.c.o.: fda approval of cablivi for acquired thrombotic thrombocytopenic purpura
-
8:31
fda d.i.s.c.o.: first biosimilar approval for the treatment of cancer
-
0:37
first gene therapy approval for bladder cancer ... is what happened
-
1:34
dr. garcia on fda approval of pembrolizumab in bladder cancer
-
1:49
fda approval of durvalumab for bladder cancer
-
24:19
femoral artery pseudoaneurysm as a complication of ivda
-
1:19:49
aioc2022 - ic127 - de mystifying the pachychoroid disease spectrum
-
32:30
bladder cancer and immunotherapy with dr. terence friedlander
-
29:46
introduction to adstiladrin | gene therapy for bcg unresponsive nmibc
-
3:19
fda approval of durvalumab for advanced bladder cancer
-
7:05
the fda approval of atezolizumab in bladder cancer
-
6:31
fda d.i.s.c.o.: avelumab in merkel cell carcinoma
-
0:40
nadofaragene firadenovec shows durable responses in nmibc
-
8:21
fda approval of a biosimilar, priority review in epithelioid sarcoma, and more
-
2:59
dr. david spigel & fda approval of vitrakvi, drug targeted to genetic mutation, not cancer
-
0:38
dr. petrylak on fda approval of pembrolizumab in bladder cancer
-
0:38
dr. siefker-radtke on fda approval of avelumab in bladder cancer
-
9:00
fda d.i.s.c.o.: two approvals for alk-positive non-small cell lung cancer
-
0:37
dr. petrylak on fda approval of nivolumab in bladder cancer
-
7:35
fda approval for abemaciclib